Special items: Ovarian Cancer and Us blog best viewed in Firefox

Tuesday, April 13, 2010

Which factors predict bowel complications in patients with recurrent epithelial ovarian cancer being treated with bevacizumab? (Avastin)


No comments:

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.